Hu Chengcheng, Zhou Mi, Wang Wenzhao, Sun Xianyun, Yarden Oded, Li Shaojie
State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
Front Microbiol. 2018 Jan 17;9:9. doi: 10.3389/fmicb.2018.00009. eCollection 2018.
Fungi transcriptionally upregulate expression of azole efflux pumps and ergosterol biosynthesis pathway genes when exposed to antifungal agents that target ergosterol biosynthesis. To date, these transcriptional responses have been shown to be dependent on the presence of the azoles and/or depletion of ergosterol. Using an inducible promoter to regulate , which encodes the major azole target, sterol 14α-demethylase, we were able to demonstrate that the CDR4 azole efflux pump can be transcriptionally activated by ergosterol biosynthesis inhibition even in the absence of azoles. By analyzing ergosterol deficient mutants, we demonstrate that the transcriptional responses by and, unexpectedly, genes encoding ergosterol biosynthesis enzymes ( genes) that are responsive to azoles, are not dependent on ergosterol depletion. Nonetheless, deletion of , which encodes C-8 sterol isomerase, also induced expression of . Deletion of also induced the expression of , the gene encoding C-14 sterol reductase, but not other tested genes which were responsive to inactivation. This indicates that inhibition of specific steps of ergosterol biosynthesis can result in different transcriptional responses, which is further supported by our results obtained using different ergosterol biosynthesis inhibitors. Together with the sterol profiles, these results suggest that the transcriptional responses by and genes are associated with accumulation of specific sterol intermediate(s). This was further supported by the fact that when the mutant was treated with ketoconazole, upstream inhibition overrode the effects by downstream inhibition on ergosterol biosynthesis pathway. Even though expression is associated with the accumulation of sterol intermediates, intra- and extracellular sterol analysis by HPLC-MS indicated that the transcriptional induction of did not result in efflux of the accumulated intermediate(s). This study demonstrates, by detailed genetic and chemical analysis, that transcriptional responses by a major efflux pump and genes of the ergosterol biosynthesis pathway to ergosterol biosynthesis inhibitors can be independent of the presence of the drugs and are linked with the accumulation of ergosterol intermediate(s).
当暴露于靶向麦角甾醇生物合成的抗真菌剂时,真菌会转录上调唑类外排泵和麦角甾醇生物合成途径基因的表达。迄今为止,这些转录反应已被证明依赖于唑类的存在和/或麦角甾醇的消耗。使用诱导型启动子来调控编码主要唑类靶点——甾醇14α-脱甲基酶的基因,我们能够证明即使在没有唑类的情况下,麦角甾醇生物合成抑制也能转录激活CDR4唑类外排泵。通过分析麦角甾醇缺陷型突变体,我们证明,以及出乎意料的是,对唑类有反应的编码麦角甾醇生物合成酶的基因(基因)的转录反应不依赖于麦角甾醇的消耗。尽管如此,编码C-8甾醇异构酶的基因的缺失也诱导了的表达。基因的缺失也诱导了编码C-14甾醇还原酶的基因的表达,但没有诱导其他对基因失活有反应的测试基因的表达。这表明麦角甾醇生物合成特定步骤的抑制可导致不同的转录反应,我们使用不同麦角甾醇生物合成抑制剂获得的结果进一步支持了这一点。连同甾醇谱,这些结果表明和基因的转录反应与特定甾醇中间体的积累有关。当突变体用酮康唑处理时,上游抑制作用超过了下游抑制对麦角甾醇生物合成途径的影响,这进一步支持了这一点。尽管的表达与甾醇中间体的积累有关,但通过HPLC-MS进行的细胞内和细胞外甾醇分析表明,的转录诱导并未导致积累的中间体流出。这项研究通过详细的遗传和化学分析表明,主要外排泵和麦角甾醇生物合成途径基因对麦角甾醇生物合成抑制剂的转录反应可以独立于药物的存在,并与麦角甾醇中间体的积累有关。